BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

STADA partners with BIAL to bring Ongentys to Parkinson’s patients in Australia

STADA receives from BIAL exclusive rights to market and distribute Ongentys (opicapone) capsules in Australia STADA Specialty Head Bryan Kim: "Ongentys ...

December 19, 2022 | News

Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

Actinogen Medical Limited (ASX: ACW) is pleased to announce that the first patient has been randomized and treated in the XanaCIDD Phase 2 depression ...

December 15, 2022 | News

Eisai and Washington University School of Medicine in St. Louis Enter Into Comprehensive Research Collaboration Agreement Aiming to Create New Therapies for Neurodegenerative Diseases

Washington University is world leading in research on prevention, diagnosis, biomarkers and treatment of neurodegenerative diseases. The two organizations ...

December 15, 2022 | News

Over £175 million for cutting-edge genomics research to help boost diagnosis treatment for patients

£105 million to speed up diagnosis of rare genetic diseases in newborns, potentially resulting in life-saving interventions for thousands of babies...

December 15, 2022 | News

HUMAN celebrates its 50th anniversary

From reagent specialist to global player with a broad network of long-standing distribution partners in more than 160 countries • Covering a compre...

December 05, 2022 | News

1 in 3 women suffer from Iron Deficiency symptoms including tiredness and dizziness

Launches 'Sangobion Anaemia meter', a convenient online tool that empowers consumers to screen themselves for the risks of iron deficiency, the most c...

November 28, 2022 | News

Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver more Medicines to Patients Faster

Company aims to launch one new product or indication every 1.5 years on average, bolstered by external innovation Phase III assets xevinapant and evobru...

November 23, 2022 | News

First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy

TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of Telix's lead therapeutic clinical programs and has been granted orphan drug designation ...

November 22, 2022 | News

Swedish and Jordanian royalty inaugurate Elekta radiation therapy devices for cancer and brain disease

Dignitaries from Sweden and Jordan attended the inauguration of two of Elekta’s (EKTA-B.ST) cancer care technologies, including an advanced linear ac...

November 18, 2022 | News

Research on neural dynamics wins 2022 Eppendorf & Science Prize

By comparing the activation of neurons in multiple deep brain regions, she identifies differences between them that point to the role each region plays in ...

November 04, 2022 | News

Neurosteer Announces FDA Clearance of the Neurosteer EEG Brain Monitoring Platform

Neurosteer Inc. announced the FDA clearance of its Neurosteer® single-channel EEG brain monitoring platform. This clearance allows Neurostee...

November 04, 2022 | News

New cell population identified in Alzheimer's Disease allows better targeting of macrophage populations in treatment of neurodegeneration

An Immunity research study has found that the previously identified disease associated microglia (DAM) population detected in murine Alzheimer’s dise...

October 11, 2022 | News

Closer Study of Major Autism Gene Suggests Possible Treatment Approach

Research led by a scientist at Cincinnati Children's who primarily studies brain tumors may open doors for improved treatment of autism. Autism spec...

September 26, 2022 | News

Persistent Loss of Smell Due to Covid-19 Closely Connected to Long-Lasting Cognitive Problems

Also, ICU Stay May Double Risk of Dementia in Older Adults SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights into factors that may...

August 01, 2022 | News

Stay Connected